Smoking cessation aid coverage by Medicaid, private insurers urged by AMA delegates.
This article was originally published in The Tan Sheet
Executive Summary
FDA-APPROVED SMOKING CESSATION "PHARMACOTHERAPY" COVERAGE by Medicaid and private sector insurers is recommended in a resolution passed by the American Medical Association House of Delegates June 17 during AMA's annual meeting in Chicago. The phrase "FDA-approved pharmacotherapy" is a compromise between supporters of the original language of a committee resolution dealing with smoking cessation, which refers to "prescription medications," and some delegates who would have preferred the resolution to explicitly include OTC therapies as well.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning